Globus Medical GMED Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)

Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at other companies

IAR

Integra LifeSciencesIART

$91.5M-6.0%

CONMEDCNMD

$34.51M-11.8%

MedtronicMDT

——

FAQ

What is Globus Medical's finite-lived intangible assets - expected amortization expense (year one)?

Globus Medical (GMED) reported finite-lived intangible assets - expected amortization expense (year one) of $116.35M in Q2 2026.

How has Globus Medical's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?

Globus Medical's finite-lived intangible assets - expected amortization expense (year one) increased by 5.2% year-over-year, from $110.65M to $116.35M.

What is the long-term trend for Globus Medical's finite-lived intangible assets - expected amortization expense (year one)?

Over 4 years (2020 to 2024), Globus Medical's finite-lived intangible assets - expected amortization expense (year one) has grown at a 68.8% compound annual growth rate (CAGR), from $12.83M to $104.07M.

What does finite-lived intangible assets - expected amortization expense (year one) mean?

This metric forecasts the amortization expense expected to be recognized in the upcoming fiscal year for intangible assets with finite useful lives. It provides visibility into the non-cash earnings impact of previously acquired intangible assets. Analysts use this to refine future earnings projections and cash flow models.